The major depressive disorder clinical trial analysis report delivers important insights into ongoing research of 75+ pipeline major depressive disorder drugs, clinical strategies, upcoming ...

Prescription-only treatment gives clinicians a new way to treat eligible adults with moderate to severe major depressive ...

Researchers at Emory University have provided compelling evidence supporting the existence of an inflammatory subtype of major depression, a breakthrough that could transform how this complex disorder ...

Xenon Pharmaceuticals Inc. (XENE:NASDAQ) shares were down 30%, on Friday morning after the company voluntarily halted new enrollment in major depressive disorder and bipolar depression studies. The ...

Please provide your email address to receive an email when new articles are posted on . Major depression is a common reason patients experience poor outcomes. Even after depression is diagnosed, it ...

Patients with major depressive disorder (MDD) and an inadequate response to standard antidepressants who received add-on ...

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

Major depressive disorder (MDD), perhaps the most common form of depression (APA, 2013), has many subtypes, each with its unique characteristics and treatment needs. I was recently reviewing this with ...

Auvelity is a medicine for major depressive disorder, commonly known as depression. It was approved by the FDA in 2022. It is an oral tablet that contains a combination of two medicines called ...

Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not gotten ...